NCT01697644View on ClinicalTrials.gov

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

PHASE4CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

October 31, 1990

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Foetal Growth ProblemSmall for Gestational Age
Interventions
DRUG

somatropin

3 IU/m\^2/day. Dose adjusted approximately every 3 months. Injected subcutaneously once daily

DRUG

somatropin

3 IU/m\^2/day. Dose adjusted approximately every 3 months. Injected subcutaneously once daily

Trial Locations (2)

3015 CN

Novo Nordisk Investigational Site, Rotterdam

3015 GJ

Novo Nordisk Investigational Site, Rotterdam

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY